Comparing a new nerve block to the commonly used standard for pain management in upper abdominal surgeries

Comparing analgesic efficacy of bilateral continuous external oblique intercostal plane block and thoracic epidural analgesia in supra-umbilical laparotomies: a randomized, non-inferiority trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056973

Enrollment

Registered

2023-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K639- Disease of intestine, unspecified Health Condition 2: K319- Disease of stomach and duodenum, unspecified Health Condition 3: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere Health Condition 4: O- Medical and Surgical

Interventions

Intervention1: External Oblique Intercostal Plane Block: Bilateral, USG guided, 6th- 7th intercostal space , 15 ml 0.125% Bupivacaine injection + catheter insertion with continuous infusion post-opera

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II patients undergoing elective laparotomies by supra - umbilical incisions

Exclusion criteria

Exclusion criteria: 1. Patient suffering from chronic pain 2. Allergy or adverse reactions to any of the study drug 3. Any coagulopathies

Design outcomes

Primary

Measure	Time frame
VAS scores at rest for 24 hours following extubation after surgeryTimepoint: VAS scores at rest for 24 hours following extubation after surgery	—

Secondary

Measure	Time frame
Block related complicationsTimepoint: 3 months;Chronic painTimepoint: 3 months;Quality of recovery & patient satisfaction scores using QoR15 questionnaireTimepoint: 24 & 72 hours;Total fentanyl consumptionTimepoint: 24, 48 & 72 hours;VAS scores on coughing & restTimepoint: 48 & 72 hours	—

Countries

India

Contacts

Public ContactDr. Shravani Jadhav

AIIMS Bhubaneswar

mitra.jayanta@gmail.com9433798583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026